Scarica l'app Stockscreener
0.84
5.00%
0.04
Precedente Chiudi:
$0.80
Aprire:
$0.78
Volume 24 ore:
90,498
Relative Volume:
2.36
Capitalizzazione di mercato:
$27.50M
Reddito:
$1.13M
Utile/perdita netta:
$-20.74M
Rapporto P/E:
-0.9545
EPS:
-0.88
Flusso di cassa netto:
$-18.37M
1 W Prestazione:
+23.53%
1M Prestazione:
+33.33%
6M Prestazione:
-30.58%
1 anno Prestazione:
-48.15%
Intervallo 1D:
$0.761
$0.86
Intervallo di 1 settimana:
$0.6634
$0.86
Portata 52W:
$0.55
$2.115
Cyclo Therapeutics Inc Stock (CYTH) Company Profile
Nome
Cyclo Therapeutics Inc
Settore
Telefono
386-418-8060
Indirizzo
6714 NW 16TH STREET, SUITE B, GAINESVILLE
Confronta CYTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYTH
Cyclo Therapeutics Inc
|
0.84 | 27.50M | 1.13M | -20.74M | -18.37M | -0.88 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Cyclo Therapeutics Inc Borsa (CYTH) Ultime notizie
Cyclo Therapeutics Faces Potential Delisting Due to Failure to Hold Annual Shareholders MeetingUNITED STATES SECURITIES AND EXCHANGE COMMISSION, Washington, D.C. – January 10, 2025 – ON January 10, 2025, Cyclo Therapeutics, Inc. (the “C - Defense World
Rafael Holdings reports favorable shareholder votes - Investing.com India
Cyclo Therapeutics to Present Groundbreaking Trappsol® Cyclo™ Research at WORLDSymposium 2025 - StockTitan
Cyclo Therapeutics faces Nasdaq delisting over meeting lapse - Investing.com
Sypris Solutions, Inc (SYPR): Worth A Small Bite At $2.12 - Stocks Register
AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com
Cyclo Therapeutics, Inc. announced that it has received $1 million in funding - Marketscreener.com
Cyclo Therapeutics Enters into Significant Note Purchase Agreement with Rafael Holdings - Defense World
Cyclo Therapeutics inks $3M convertible note with Rafael Holdings By Investing.com - Investing.com Nigeria
Cyclo Therapeutics inks $3M convertible note with Rafael Holdings - Investing.com
CYTH stock touches 52-week low at $0.57 amid market challenges - Investing.com Australia
CYTH stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa
Critical Comparison: Curis (NASDAQ:CRIS) vs. Cyclo Therapeutics (NASDAQ:CYTH) - Defense World
Rafael Holdings Reports Conversion of Convertible Promissory Note into Cyclo Therapeutics Common Stock - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, SASR, AUB, CYTH on Behalf of Shareholders - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, LTRPB, CYTH, SKGR on Behalf of Shareholders - Benzinga
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerZUO, CYTH, PDCO, SKGR - The Eastern Progress Online
Niemann-Pick Disease Type C Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Zevra Therapeutics, Azafaros A.G, IntraBio, Cyclo Therapeutics, Azafaros A.G - Barchart
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
Kuehn Law Encourages USAP, CYTH, ARCH, and FLIC Investors to Contact Law Firm - EIN News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, ARCH, CYTH on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cyclo Therapeutics, Inc.CYTH - The Eastern Progress Online
$HAREHOLDER ALERT: The M&A Class Action Continues To Investigate MergerAE, ZUO, CYTH, EMKR - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders - The Eastern Progress Online
CYTH Stock Plummets to 52-Week Low of $0.59 Amid Market Challenges - Investing.com Canada
CYTH Stock Plummets to 52-Week Low of $0.59 Amid Market Challenges By Investing.com - Investing.com South Africa
Rafael Holdings: Strategic Developments and Financial Insights - TipRanks
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
Rafael Holdings Reports Widening Losses Ahead of Strategic Cyclo Therapeutics Merger - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENLC, ALVR, CYTH on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, NAPA, MNTX and MARX - The Eastern Progress Online
Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm - The Eastern Progress Online
Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, BRKH, PIRS, CFB on Behalf of Shareholders - The Eastern Progress Online
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, VBFC, CFB and MKFG - The Eastern Progress Online
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of BFAC, BCOV, CYTH and ARCH - The Eastern Progress Online
Cyclo Therapeutics Inc Azioni (CYTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):